Shilpa Medicare Limited has informed the Exchange regarding Outcome and Proceedings of Annual General Meeting held on September 23, 2025
SHILPAMED · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Shilpa Medicare held its 38th AGM on September 23, 2025, via video conferencing, running from 11:00 a.m. to 11:47 a.m. Of 51,999 shareholders on the record date, 66 members attended virtually, and 10 resolutions were put to vote, including a Rs. 1.00 per equity share dividend for FY25 and a proposal to issue bonus shares. The Statutory and Secretarial Auditor reports were unqualified with no adverse observations, and several director re-appointments (including Chairman Omprakash Inani, Whole-Time Director Sharath Reddy Kalakota, and Women Independent Director Anita Bandyopadhyay) were tabled. A new Independent Director (Ashraf Loutfy Abdelhamid Allam) was also proposed, alongside a revision in remuneration for the CEO of material subsidiary Shilpa Pharma Lifesciences.
Shareholders stand to benefit from the Rs. 1 dividend and the proposed bonus share issue, while clean audit reports and seamless board continuity suggest operational stability. Results of e-voting and insta-poll are awaited but no negative surprises were flagged at the meeting.